Haynes and Boone is advising BiomX Inc. on the transaction, Cooley is advising Adaptive Phage Therapeutics and Wilmer Cutler Pickering Hale and Dorr is advising the...
You must be a Standard 1 Year member to access this content.
Cooley is serving as legal counsel to Tourmaline in connection with the private placement and the merger, while Goodwin Procter is serving as legal counsel to...
You must be a Standard 1 Year member to access this content.
Cooley advised SoundHound AI on the deal. SoundHound AI, a leader in voice artificial intelligence, announced the closing of a new $125 million loan facility from...
You must be a Standard 1 Year member to access this content.
Cooley advised Angion on the deal. Angion, a clinical-stage biopharmaceutical company, announced its definitive merger agreement with Elicio Therapeutics. Elicio will merge with a wholly owned subsidiary...
You must be a Standard 1 Year member to access this content.
Cooley advised Justin Bieber on the deal. Justin Bieber announced a $200 million deal to sell his music rights to Blackstone-backed Hipgnosis Songs Capital. The deal is...
You must be a Standard 1 Year member to access this content.
Covington & Burling advised AstraZeneca. Skadden represented Centerview Partners LLC, the exclusive financial advisor to CinCor Pharma Inc. Cooley advised CinCor Pharma. CinCor Pharma Inc. (“CinCor”)...
You must be a Standard 1 Year member to access this content.
Cooley LLP and Matheson LLP advised Horizon, while Sullivan & Cromwell LLP and William Fry LLP advised Amgen. Debevoise & Plimpton LLP advised JP Morgan. Macfarlanes...
You must be a Standard 1 Year member to access this content.
Cooley LLP advised Apollo Endosurgery on the deal, while Shearman & Sterling advised Boston Scientific Corporation. Apollo Endosurgery, a medical device company, signed the agreement to be...
You must be a Standard 1 Year member to access this content.
Ropes & Gray and Cooley advised 1Life Healthcare Inc., which operates under the name One Medical, on the deal, while Crowell & Moring and Paul, Weiss,...
You must be a Standard 1 Year member to access this content.
Cooley advised Turning Point Therapeutics, while Kirkland & Ellis advised Bristol Myers Squibb on the deal. Bristol Myers Squibb (NYSE:BMY), a global biopharmaceutical company, announced its...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Pfizer Inc. in the deal, while Cooley represented Arena Pharmaceuticals. Debevoise & Plimpton advised Evercore Group and Guggenheim Securities as financial advisors...
You must be a Standard 1 Year member to access this content.
Cooley LLP advised NeoPhotonics on the deal. NeoPhotonics, a developer and manufacturer of optoelectronic solutions, announced its agreement to sell to Lumentum for $918 million. The acquisition...
You must be a Standard 1 Year member to access this content.
